Zobrazeno 1 - 10
of 26
pro vyhledávání: '"НОВЫЕ ОРАЛЬНЫЕ АНТИКОАГУЛЯНТЫ"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 66-72 (2019)
Tis article presents a literature review of hepatotoxicity of new oral anticoagulants which was obtained by different methods options of pharmacovigilance. Te overview includes 35 information sources 24 articles, 4 methodic or regulatory guidelines,
Externí odkaz:
https://doaj.org/article/df906578779f45c29a130ac442bdd7f0
Autor:
I. S. Yavelov
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 36-45 (2015)
Stroke is one of the most serious cardiovascular events with severe consequences, up to paralysis and death. Patients at high risk of stroke include those with atrial fibrillation; in such patients prevention of stroke is particularly relevant. The a
Externí odkaz:
https://doaj.org/article/a2d19c74446c4ec08e39740ef56a1c38
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 14, Iss 5, Pp 48-52 (2015)
Aim. To compare, in what extent are the patients with atrial fibrillation (AF), included into three large randomized clinical trials (RCT) of the new oral anticoagulants (NOAC), comparable with Russian patients with AF. Material and methods. We revea
Externí odkaz:
https://doaj.org/article/1f8fbab2c7134a65978c8d7b8f5ecf92
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 6, Pp 634-639 (2015)
Despite large number of known risk factors of venous thromboembolism (VTE) in cancer patients existing prediction models do not allow definite identification of cancer patients that have indications for anticoagulant prevention. Besides, heparin and
Externí odkaz:
https://doaj.org/article/70e0d63e0b394ec19770bb724b684e1a
Autor:
О. О. Шахматов, Е. П. Панченко
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 52-64 (2015)
Сердечно-сосудистые заболевания — наиболее распространенные патологии в России. Они обусловливают более 50% летальных случаев, значите
Externí odkaz:
https://doaj.org/article/57b9f45641db43d1be9768613ba0419e
Publikováno v:
Атеротромбоз, Vol 0, Iss 2, Pp 58-69 (2014)
Высокая распространенность тромботических осложнений у пациентов с сердечно-сосудистыми заболеваниями обусловила широкое применение
Externí odkaz:
https://doaj.org/article/b1b399d6380547299905bf25c84ab3b5
Autor:
I. A. Filippova
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 99-101 (2013)
Venous thromboembolism (VTE) is caused by the formation of blood clots within a vein resulting in vein occlusion and risk of blood clots travelling to the pulmonary arteries. VTE manifestations are deep vein thrombosis (DVT) and pulmonary embolism (P
Externí odkaz:
https://doaj.org/article/260d7fc291ba47f194053314b48ed927
Publikováno v:
EMERGENCY MEDICINE; Vol. 16 No. 7-8 (2020); 93-105
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16 № 7-8 (2020); 93-105
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16 № 7-8 (2020); 93-105
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16 № 7-8 (2020); 93-105
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16 № 7-8 (2020); 93-105
Based on the analysis of recent multidisciplinary recommendations from France, Italy, Spain, Great Britain, USA, Poland, the guidelines of the European Society of Anesthesiology and Intensive Care, the American College of Chest Physicians, etc. and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::45062159f5316e82851fcbaa6409c64a
http://emergency.zaslavsky.com.ua/article/view/223710
http://emergency.zaslavsky.com.ua/article/view/223710
Publikováno v:
Pain, Anaesthesia and Intensive Care; No. 1(94) (2021); 65-77
PAIN, ANAESTHESIA & INTENSIVE CARE; № 1(94) (2021); 65-77
PAIN, ANAESTHESIA & INTENSIVE CARE; № 1(94) (2021); 65-77
The management of antithrombotic drugs in the perioperative period requires a multidisciplinary approach with the participation of the operating surgeon, anesthesiologist, and a responsible physician. In the guidelines of the leading specialized asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::efd359ea018412cf72618bed518c8ef5
http://jpaic.aaukr.org/article/view/230618
http://jpaic.aaukr.org/article/view/230618
Показаниями к назначению антикоагулянтной терапии являются профилактика инфаркта мозга, системной тромбоэмболии при фибрилляции пред
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbc39b72786c7b9025bbaba8b0721dc6
